A detailed history of Twin Lakes Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 511 shares of BIIB stock, worth $80,686. This represents 0.07% of its overall portfolio holdings.

Number of Shares
511
Previous 511 -0.0%
Holding current value
$80,686
Previous $118,000 16.1%
% of portfolio
0.07%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021

SELL
$282.99 - $369.05 $4,810 - $6,273
-17 Reduced 3.22%
511 $145,000
Q1 2021

May 18, 2021

BUY
$242.95 - $284.63 $128,277 - $150,284
528 New
528 $148,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Twin Lakes Capital Management, LLC Portfolio

Follow Twin Lakes Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Lakes Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Lakes Capital Management, LLC with notifications on news.